Effects of Hip Abductor Strengthening Exercises in Patients With Piriformis Syndrome

March 16, 2026 updated by: Riphah International University

Effects of Hip Abductor Strengthening Exercises on Pain, Range of Motion and Lower Extremity Function in Patients With Piriformis Syndrome

The study was conducted to determine the effects of hip abductor strengthening exercises on pain, range of motion, and lower extremity function in patients with piriformis syndrome.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 40100
        • Hashir Ali clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Males and Females between 18 and 45 .
  • Unilateral involvement, Onset of pain not > 2 weeks.
  • Grade 1-3 Tenderness at piriformis muscle.
  • Numeric pain rating scale>3and equal to, <6.
  • Any three positive test among Piriformis Test, Beatty Test, Freiberg Test, FAIR Test, Sign of Pace & Nagel.

Exclusion Criteria:

Positive Leagues' sign.

  • Any pathology or recent injury around hip, knee and SI joint .
  • Fracture of femur & hip joint dislocation.
  • Pain due to neurological, spinal or pelvic origin.
  • Limb length discrepancy .
  • Stenosis of spine and disc herniation .
  • Any postural abnormality/ deformity .
  • Tumors and facet joint pathology.
  • Congenital or acquired abnormality in the spinal column .
  • Pregnancy .
  • Neurological conditions like, CVA, Parkinson's disease, non-cooperative & subjects with psychological impairment .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Hip Abductor Strengthening Exercise Group + conventional physiotherapy

Experimental Group (Hip Abductor Strengthening + Baseline Physiotherapy) A structured hip abductor strengthening program divided into three progressive phases over four weeks, along with baseline physiotherapy treatment.

Phase I (Week 1 - Non-weight bearing / Isolated activation) Exercises: Bridging, Side-lying clam exercises, Side-lying hip abduction, Towel squeeze Dosage: 3 × 15 repetitions Phase II (Week 2 - Weight-bearing strengthening) Exercises: Squats, Side-stepping, Single-limb sit-to-stand, Step-up/Step-down, Leg press Dosage: 3 × 15 repetitions Phase III (Weeks 3-4 - Dynamic/Functional training) Exercises: Forward lunges, Double-limb jump Dosage: Week 3 → 3 × 15 repetitions Week 4 → 5 × 20 repetitions

conventional Physiotherapy treatment

  • Hydro-collateral pack for 10 minutes over piriformis muscle (40°C)
  • Pulsed ultrasound for 10 minutes at 2.25 W/cm²
  • Piriformis stretching maneuver (20-second hold × 10 repetitions)
Active Comparator: Arm 2: Conventional Physiotherapy Group

conventional Physiotherapy treatment

  • Hydro-collateral pack for 10 minutes over piriformis muscle (40°C)
  • Pulsed ultrasound for 10 minutes at 2.25 W/cm²
  • Piriformis stretching maneuver (20-second hold × 10 repetitions)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower Extremity Functional Scale (LEFS)
Time Frame: From enrolment to the end of treatment at 4 weeks
The Lower Extremity Functional Scale (LEFS) is a self-reported questionnaire used to assess lower extremity functional status in individuals with musculoskeletal conditions. It consists of 20 items related to daily activities such as walking, climbing stairs, squatting, and running. Each item is scored on a 5-point Likert scale (0 = extreme difficulty/unable to perform, 4 = no difficulty), with a maximum total score of 80. Higher scores indicate better functional ability. The LEFS is widely used due to its high reliability, validity, and responsiveness in evaluating functional improvement over time.
From enrolment to the end of treatment at 4 weeks
Numeric Pain Rating Scale (NPRS)
Time Frame: from enrollment to the end of treatment at 4 weeks
The Numeric Pain Rating Scale (NPRS) is a subjective measure used to assess pain intensity. Patients are asked to rate their current pain level on a scale from 0 to 10, where 0 represents "no pain" and 10 represents "worst imaginable pain." It is simple, quick to administer, and clinically reliable for monitoring changes in pain over time. A reduction of 2 points or more is generally considered clinically meaningful improvement
from enrollment to the end of treatment at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip Abduction range of motion
Time Frame: from enrollment to the end of treatment.
Changes in hip abduction range of motion at baseline and 4 weeks of intervention were measured using a universal goniometer.
from enrollment to the end of treatment.
Hip external roration ROM
Time Frame: From enrollment to the end of treatment at 4 weeks.
Changes in hip external rotation range of motion at baseline and 4 weeks of intervention were measured using a universal goniomete
From enrollment to the end of treatment at 4 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Humera Mubashar, Ms-OMPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2025

Primary Completion (Actual)

May 31, 2025

Study Completion (Actual)

October 31, 2025

Study Registration Dates

First Submitted

March 16, 2026

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Piriformis Syndrome

Clinical Trials on Progressive Hip Abductor Strengthening Exercises

Subscribe